retatrutide vendors and the Grey Market: Buyer Beware – Sarah Hormachea Phase III retatrutide study demonstrates

They come with a US Boxed Warning of a risk of thyroid C-cell tumors and medullary thyroid carcinoma and are contraindicated in patients with multiple endocrine neoplasia syndrome type 2

This pathway is legal, provided the patient holds a valid prescription from a licensed practitioner and the medication is for personal use (not commercial resale)

Medication Dose and Tolerance A doctor may review the current dose, how long the patient has been at that dose, whether side effects are present, and whether the medication is being used consistently

That is the promise behind Pendulum GLP-1 Probiotic Pro

This supports the value of GLP-1 receptor agonists in personalized healthcare strategies

Cooper TC, Simmons EB, Webb K, Burns JL, Kushner RF